Replacing the Missing Link: How Enzyme Replacement Therapy and Lysosomal Storage Disorder Management are Transforming Rare Disease Care
The field of rare disease therapeutics has been revolutionized by the development of enzyme replacement therapy (ERT) , a targeted approach that has dramatically improved outcomes for patients with lysosomal storage disorders (LSDs) . Fabry disease, a prime example of an LSD, is caused by a genetic deficiency of the enzyme alpha-galactosidase A. This deficiency leads to the...
0 Yorumlar 0 hisse senetleri 2 Views 0 önizleme